- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05120232
Flourishing and Virtue in Cognitive-Behavioral Therapy for Anxiety and Depressive Disorders
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Research shows that positive emotions can buffer against the effects of stress as well as contribute to overall well-being and functioning. People with emotional disorders, such as anxiety and depression, often report lower levels of positive emotions. However, to date, most existing treatment approaches for emotional disorders focus on regulating negative emotions, without explicitly focusing on positive emotions.
The Unified Protocol (UP) is a transdiagnostic, cognitive-behavioral therapy that has been shown to be effective for treating emotional disorders. The UP targets negative emotions and helps people respond to their emotions in ways that are more helpful for them and in line with their goals. In its current form, the UP does not explicitly target positive emotions, but some research suggests that individuals treated with the UP and other cognitive-behavioral treatments experience some improvement in positive affect.
In the current study, the researchers will create a modified version of the UP (called the UP+) delivered entirely on an online platform that will include exercises specifically designed to enhance positive emotions. Then, the researchers will evaluate the UP+ in a small sample of participants to examine acceptability and feasibility and will then use this information to continue to refine the protocol. Finally, the researchers will conduct a randomized controlled trial to assess the efficacy of the UP+. Participants diagnosed with emotional disorders will be randomized to either receive the UP or the UP+ delivered on an online platform and will be assessed on a range of outcomes, including positive and negative affect, psychological symptoms, and functional outcomes.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Todd Farchione, Ph.D.
- Phone Number: 617-353-9609
- Email: tfarchio@bu.edu
Study Contact Backup
- Name: Audrey Hey
- Phone Number: (617) 353-2000
- Email: ajhey@bu.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Center for Anxiety and Related Disorders - Boston University
-
Contact:
- Todd J Farchione, PhD
- Phone Number: 627-353-9610
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Diagnosed with a DSM-5 anxiety, obsessive-compulsive, or depressive disorder
Exclusion Criteria:
Acute risk factors (suicidal or homicidal ideation or clinical condition requiring immediate treatment);
The individual is in treatment elsewhere for related issues; and/or
The individual is considering changing their treatment and and/or psychotropic medication during the time period in which they would be enrolled in the study and/or
The individual is unable or unwilling to commit to the study procedures.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Unified Protocol (UP)
The Unified Protocol (UP) is a transdiagnostic, cognitive-behavioral therapy that has been shown to be effective for treating emotional disorders.
The UP targets negative emotions and helps people respond to their emotions in ways that are more helpful for them and in line with their goals.
This will be delivered entirely on an online platform.
|
A transdiagnostic, cognitive behavioral therapy.
|
Experimental: Modified Unified Protocol (UP+)
A modified version of the UP (called the UP+) delivered entirely on an online platform that will include exercises specifically designed to enhance positive emotions.
|
A transdiagnostic, cognitive behavioral therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Anxiety and Related Disorders Interview Schedule for Diagnostic and Statistical Manual-5 (ADIS-5) Score
Time Frame: Baseline, 12-weeks following baseline, 3 months following the treatment phase
|
This semi-structured, diagnostic clinical interview focuses on Diagnostic and Statistical Manual-5 diagnoses of anxiety disorders and their accompanying mood states, somatoform disorders, and substance and alcohol use.
The information derived from the interview using the ADIS allows clinicians to determine differential diagnoses and gain a clear understanding of the level and severity of each diagnosis.
Principal and additional diagnoses are assigned a clinical severity rating (CSR) on a scale from 0 (no symptoms) to 8 (extremely severe symptoms), with a rating of 4 or above (definitely disturbing/disabling) passing the clinical threshold for DSM diagnostic criteria.
Inquiries about suicidal ideation are part of this interview.
This measure has demonstrated excellent to acceptable interrater reliability for the anxiety and mood disorders (Brown, Di Nardo, et al., 2001).
|
Baseline, 12-weeks following baseline, 3 months following the treatment phase
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Positive and Negative Affect Schedule Expanded Form (PANAS-X) Score
Time Frame: Baseline, every week through 12-weeks following baseline, 3 months following the treatment phase
|
The PANAS-X is a brief, reliable and valid measure of positive and negative affect.
It consists of 20 feeling or emotion words (e.g., interested, upset, nervous).
Respondents rate each emotion word on a scale ranging from 1 = very slightly or not at all to 5 = extremely, indicating the extent to which they experience that emotion or feeling in general.
The PANAS-X has shown excellent convergent and discriminant correlations with lengthier measures of underlying mood factors and is a widely used measure of state negative affect (Watson et al., 1988).
|
Baseline, every week through 12-weeks following baseline, 3 months following the treatment phase
|
Change in Savoring Beliefs Inventory (SBI) Score
Time Frame: Baseline, every week through 12-weeks following baseline, 3 months following the treatment phase
|
The SBI is a measure of one's tendency to savor or dampen positive emotions (Bryant, F. B. 2003).
It includes distinctions among future, present, and past focused forms of savouring.
The SBI includes 24 items with 4 positively-worded and 4 negatively-worded items for each of the three temporal forms of savoring (rated on a 7-point scale from 1 = strongly agree to 7 = strongly disagree) .
Overall, the SBI is a valid and reliable measure of individuals' beliefs about their capacity to savour positive experiences (Bryant 2003).
|
Baseline, every week through 12-weeks following baseline, 3 months following the treatment phase
|
Change in Flourish Index (FI) Score
Time Frame: Baseline, every week through 12-weeks following baseline, 3 months following the treatment phase
|
The FI is a measurement approach to human flourishing, based around five central domains: happiness and life satisfaction, mental and physical health, meaning and purpose, character and virtue, and close social relationships.
The FI consists of 10 questions on a 10 point Likert scale (with 0 = strongly disagree to 10 = strongly agree) (VanderWeele, 2017).
The FI has demonstrated good internal consistency and evidence of validity and reliability (Węziak-Białowolska et al, 2019).
|
Baseline, every week through 12-weeks following baseline, 3 months following the treatment phase
|
Collaborators and Investigators
Investigators
- Principal Investigator: Todd Farchione, Ph.D., Center for Anxiety Related Disorders at Boston University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 61245
- 5724E (Other Identifier: BU CRC IRB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Disorder
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Shalvata Mental Health CenterUnknownMAjor Depressive DisorderIsrael
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedDepressive Disorder, Major Depressive DisorderUnited States
-
Samsung Medical CenterUnknownMajor Depressive Disorder, Anxiety DisorderKorea, Republic of
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDD)India
-
Repurposed Therapeutics, Inc.Unknown
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)United States
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDDIndia
-
Gangnam Severance HospitalCompletedMajor Depressive Disorder(MDD)Korea, Republic of
-
University College, LondonCompletedUnipolar Major Depressive DisorderUnited Kingdom
Clinical Trials on Unified Protocol
-
Kessler FoundationRecruiting
-
University of Buenos AiresNot yet recruitingTo Assess the Clinical Usefulness and Acceptability Level of the UP Online Group Format in Argentina as Well as Participants' SatisfactionArgentina
-
Örebro University, SwedenÖrebro County Council; Uppsala County Council, SwedenCompletedChronic Pain and Comorbid Emotional Problems
-
Rutgers, The State University of New JerseyNational Institute of Mental Health (NIMH); Massachusetts General HospitalRecruitingEmotion Regulation | Suicide and Self-harmUnited States
-
Duke UniversityNational Institute on Aging (NIA)Active, not recruiting
-
Fundació Institut de Recerca de l'Hospital de la...Active, not recruitingEmotional EatingSpain
-
Boston University Charles River CampusNational Institute of Mental Health (NIMH)CompletedMood Disorders | Anxiety DisordersUnited States
-
Northwestern UniversityCompletedLower Urinary Tract Symptoms | Urinary Incontinence | Anxiety | Pelvic Floor Disorders | Nocturia | Urinary Urgency | Urinary Frequency/Urgency | Urinary Hesitancy | Urinary StrainingUnited States
-
Boston UniversityNational Institute of Mental Health (NIMH)CompletedDepression | Anxiety | Traumatic Stress DisordersUnited States
-
The University of Hong KongRecruitingQuality of Life | Insomnia | Depression, AnxietyHong Kong